Utility of Serum Procalcitonin as a Biomarker to Determine the Duration of Antibiotic Therapy in Adult Patients with Sepsis and Septic Shock in Intensive Care Units
Background: Procalcitonin is a biomarker used to determine the length of antibiotic therapy in sepsis patients. The severity of systemic infection and the existence of...
Study on Procalcitonin as a Prognostic Indicator and as an Early Biomarker in Grading of Sepsis
The goal of this study was to look into the pattern of PCT rise in sepsis. To see if PCT rises earlier than other sepsis...
Our Four Years of Paediatric Sepsis Treatment with Hemoadsorption, Albumin and Heparin: Let’s Give it a Chance in Multifactorial Pathological Conditions
In the realm of intensive care medicine, extracorporeal blood purification techniques are becoming more common. These methods are used in a variety of clinical settings,...
Clinical Profile and Outcomes of Acute Kidney Injury Patients in an Intensive Care Unit in India: A Retrospective Study
Background: Epidemiology and outcome data on acute renal damage are scarce in underdeveloped countries (AKI). By attempting to identify the presenting symptoms, etiologies, treatment methods,...
Studies on the Balance between Thrombomodulin and HMGB1 in Sepsis Patients
Background: In sepsis patients, the equilibrium between high mobility group box 1 (HMGB1) and thrombomodulin (TM) must be understood. The molecule HMGB1 has been linked...
Procalcitonin as a Diagnostic Biomarker of Sepsis: A Prospective Study in a Tertiary Care Centre
Introduction: Despite advances in diagnostic methods, sepsis remains a significant cause of morbidity and mortality. It is still difficult to distinguish between sepsis and non-infectious...
Morphometric Parameters of Leukocytes in the Management of Sepsis Running Title: Cell Population Data in Sepsis
Sepsis is a medical emergency that describes the body's systemic immunological response to an infection, which can lead to organic dysfunction and death. Sepsis is...